This paper presents the case of a male dialysis patient, with generalised epilepsy, who experienced complications after starting medium cut-off (MCO) dialysis. While receiving haemodiafiltration, the patient’s epilepsy had been relatively well controlled using two antiseizure medications (brivaracetam and sodium valproate). However, the patient’s seizure frequency increased when he was changed to MCO dialysis. MCO is a new dialysis method that has been developed to allow for better clearance of uraemic toxins through its larger pore size. We hypothesise that using the highly permeable MCO membrane changed the seizure threshold by an unknown mechanism. This is the first reported case to observe increased seizure frequency in a patient receiving MCO dialysis. The case highlights the need for caution when prescribing dialysis methods to patients with epilepsy.

Objective To describe the first 9 months of a newly established computed tomography coronary angiogram (CTCA) over the period of the COVID‐19 pandemic. Methods A retrospective analysis of the first 9 months of a CT‐CA program. Design Data were collected for the period of June 2020 to March 2021. Information reviewed included demographics, risk factors, renal function, technical factors and outcomes including Calcium Score and Coronary Artery Disease Reporting and Data System (CAD‐RADS). Setting A single Rural Referral Hospital in regional New South Wales. Participants Ninety‐six CTCAs were reviewed. Ages ranged from 29 to 81 years. 37 (39%) male, 59 (61%) female. 15 (15.6%) identified as Aboriginal and/or Torres Strait Islander. Main Objective Outcomes CTCA is a viable alternative to invasive coronary angiogram in appropriate populations for regional areas. Results Eighty‐eight (91.6%) were considered technically satisfactory. Mean heart rate was 57 beats per minute with a range of 108. Cardiovascular risk factors included hypertension, dyslipidemia, smoking status, family history and diabetes mellitus. Of patients with CAD‐RADS scores 3 or 4 who underwent subsequent invasive coronary angiogram (ICA), 80% were determined to have operator‐defined significant stenosis. Significant cardiac and non‐cardiac findings were extensive. Conclusions CTCA is a safe and efficacious imaging modality for low‐ to moderate‐risk chest pain patients. There was acceptable diagnostic accuracy and the investigation was safe.